Long-Chain Polyunsaturated Fatty Acids Promote Paclitaxel Cytotoxicity via Inhibition of the MDR1 Gene in the Human Colon Cancer Caco-2 Cell Line

REFERENCES

• CalvielloGSeriniSPalozzaP n-3 polyunsaturated fatty acids as signal transduction modulators and therapeutical agents in cancer. Curr Signal Transduct Ther 1: 255– 271, 2006.
   Web of Science ®Google Scholar
• RiedigerNDOthmanRASuhMMoghadasianMH: A systemic review of the roles of n-3 fatty acids in health and disease. J Am Diet Assoc 109: 668– 679, 2009.
   PubMed Web of Science ®Google Scholar
• BaracosVEMazurakVCMaDW n-3 Polyunsaturated fatty acids throughout the cancer trajectory: influence on disease incidence, progression, response to therapy and cancer-associated cachexia. Nutr Res Rev 17: 177– 192, 2004.
   PubMed Web of Science ®Google Scholar
• StehrSNHellerAR: Omega-3 fatty acid effects on biochemical indices following cancer surgery. Clin Chim Acta 373: 1– 8, 2006.
   Google Scholar
• BerquinIMEdwardsIJChenYQ: Multi-targeted therapy of cancer by omega-3 fatty acids. Cancer Lett 269: 363– 377, 2008.
   PubMed Web of Science ®Google Scholar
• BiondoPDBrindleyDNSawyerMBFieldCJ: The potential for treatment with dietary long-chain polyunsaturated n-3 fatty acids during chemotherapy. J Nutr Biochem 19: 787– 796, 2008.
   PubMed Web of Science ®Google Scholar
• PardiniRS: Nutritional intervention with omega-3 fatty acids enhances tumor response to anti-neoplastic agents. Chem Biol Interact 162: 89– 105, 2006.
   PubMed Web of Science ®Google Scholar
• MonjazebAMHighKPConnoyAHartLSKoumenisCChiltonFH: Arachidonic acid-induced gene expression in colon cancer cells. Carcinogenesis 27: 1950– 1960, 2006.
   Google Scholar
• PerezRMataboschXLlebariaABalboaMABalsindeJ: Blockade of arachidonic acid incorporation into phospholipids induces apoptosis in U937 promonocytic cells. J Lipid Res 47: 484– 491, 2006.
   PubMed Web of Science ®Google Scholar
• GhoshJMyersCE: Arachidonic acid stimulates prostate cancer cell growth: critical role of 5-lipoxygenase. Biochem Biophys Res Commun 235: 418– 423, 1997.
   PubMed Web of Science ®Google Scholar
• FunahashiHSatakeMHasanSSawaiHNewmanRAReberHAHinesOJEiblG: Opposing effects of n-6 and n-3 polyunsaturated fatty acids on pancreatic cancer growth. Pancreas 36: 353– 362, 2008.
   PubMed Web of Science ®Google Scholar
• GottesmanMMFojoTBatesSE: Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer 2: 48– 58, 2002.
   PubMed Web of Science ®Google Scholar
• BorstPEversRKoolMWijnholdsJ: The multidrug resistance protein family. Biochim Biophys Acta 1461: 347– 357, 1999.
   PubMed Web of Science ®Google Scholar
• LoYLHuangJD: Effects of sodium deoxycholate and sodium caprate on the transport of epirubicin in human intestinal epithelial Caco-2 cell layers and everted gut sacs of rats. Biochem Pharmacol 59: 665– 672, 2000.
   PubMed Web of Science ®Google Scholar
• VialeMCordazzoCCosimelliBde ToteroDCastagnolaPAielloCSeveriEPetrilloGCianfrigliaMSpinelliD: Inhibition of MDR1 activity in vitro by a novel class of diltiazem analogues: toward new candidates. J Med Chem 52: 259– 266, 2009.
   Google Scholar
• YadavSvan VlerkenLELittleSRAmijiMM: Evaluations of combination MDR-1 gene silencing and paclitaxel administration in biodegradable polymeric nanoparticle formulations to overcome multidrug resistance in cancer cells. Cancer Chemother Pharmacol 63: 711– 722, 2009.
   PubMed Web of Science ®Google Scholar
• LageH: An overview of cancer multidrug resistance: a still unsolved problem. Cell Mol Life Sci 65: 3145– 3167, 2008.
   PubMed Web of Science ®Google Scholar
• MechetnerEKyshtoobayevaAZonisSKimHStroupRGarciaRParkerRJFruehaufP: Levels of multidrug resistance (MDR1) P-glycoprotein expression by human breast cancer correlate with in vitro resistance to taxol and doxorubicin. Clin Cancer Res 4: 389– 398, 1998.
   PubMed Web of Science ®Google Scholar
• SzakacsGPatersonJKLudwigJABooth-GentheCGottesmanMM: Targeting multidrug resistance in cancer. Nat Rev Drug Discov 5: 219– 234, 2006.
   PubMed Web of Science ®Google Scholar
• AssefYRubioFColoGdel MonacoSCostasMAKotsiasBA: Imatinib resistance in multidrug-resistant K562 human leukemic cells. Leuk Res 33: 710– 716, 2009.
   PubMed Web of Science ®Google Scholar
• FantappieOSolazzoMLasagnaNPlatiniFTessitoreLMazzantiR P-glycoprotein mediates celecoxib-induced apoptosis in multiple drug-resistant cell lines. Cancer Res 67: 4915– 4923, 2007.
   PubMed Web of Science ®Google Scholar
• KimJYKajino-SakamotoROmoriEJobinCNinomiya-TsujiJ: Intestinal epithelial-derived TAK1 signaling is essential for cytoprotection against chemical-induced colitis. PLoS One 4: e4561, 2009.
   PubMed Web of Science ®Google Scholar
• VasilukLPintoLJTsangWSGobasFAEickhoffCMooreMM: The uptake and metabolism of benzo[a]pyrene from a sample food substrate in an in vitro model of digestion. Food Chem Toxicol 46: 610– 618, 2008.
   PubMed Web of Science ®Google Scholar
• VidrichABuzanJMBrodrickBIloCBradleyLFendigKSSturgillTCohnSM: Fibroblast growth factor receptor-3 regulates Paneth cell lineage allocation and accrual of epithelial stem cells during murine intestinal development. Am J Physiol Gastrointest Liver Physiol 297: G168– G178, 2009.
   Google Scholar
• LayneKSGohYKJumpsenJARyanEAChowPClandininMT: Normal subjects consuming physiological levels of 18:3(n-3) and 20:5(n-3) from flaxseed or fish oils have characteristic differences in plasma lipid and lipoprotein fatty acid levels. J Nutr 126: 2130– 2140, 1996.
   PubMed Web of Science ®Google Scholar
• PrattVCWatanabeSBrueraEMackeyJClandininMTBaracosVEFieldCJ: Plasma and neutrophil fatty acid composition in advanced cancer patients and response to fish oil supplementation. Br J Cancer 87: 1370– 1378, 2002.
   PubMed Web of Science ®Google Scholar
• HostmarkAT: Serum fatty-acid albumin molar ratio and the risk of diseases. Med Hypotheses 44: 539– 541, 1995.
   Google Scholar
• AssayagKYakuninELoebVSelkoeDJSharonR: Polyunsaturated fatty acids induce alpha-synuclein-related pathogenic changes in neuronal cells. Am J Pathol 171: 2000– 2011, 2007.
   Google Scholar
• HoSYStorchJ: Common mechanisms of monoacylglycerol and fatty acid uptake by human intestinal Caco-2 cells. Am J Physiol Cell Physiol 281: C1106– C1117, 2001.
   PubMed Web of Science ®Google Scholar
• WatanabeSSatoT: Effects of free fatty acids on the binding of bovine and human serum albumin with steroid hormones. Biochim Biophys Acta 1289: 385– 396, 1996.
   Google Scholar
• EngelbrechtAMToit-KohnJLEllisBThomasMNellTSmithR: Differential induction of apoptosis and inhibition of the PI3-kinase pathway by saturated, monounsaturated and polyunsaturated fatty acids in a colon cancer cell model. Apoptosis 13: 1368– 1377, 2008.
   Google Scholar
• NanoJLNobiliCGirard-PipauFRampalP: Effects of fatty acids on the growth of Caco-2 cells. Prostaglandins Leukot Essent Fatty Acids 69: 207– 215, 2003.
   PubMed Web of Science ®Google Scholar
• van BeelenVARoeleveldJMooibroekHSijtsmaLBinoRJBoschDRietjensIAlinkGM: A comparative study on the effect of algal and fish oil on viability and cell proliferation of Caco-2 cells. Food Chem Toxicol 45: 716– 724, 2007.
   PubMed Web of Science ®Google Scholar
• EssodaiguiMBroxtermanHJGarnier-SuillerotA: Kinetic analysis of calcein and calcein-acetoxymethylester efflux mediated by the multidrug resistance protein and P-glycoprotein. Biochemistry 37: 2243– 2250, 1998.
   PubMed Web of Science ®Google Scholar
• LiebmannJECookJALipschultzCTeagueDFisherJMitchellJB: Cytotoxic studies of paclitaxel (Taxol) in human tumour cell lines. Br J Cancer 68: 1104– 1109, 1993.
   PubMed Web of Science ®Google Scholar
• JordanMATosoRJThrowerDWilsonL: Mechanism of mitotic block and inhibition of cell proliferation by Taxol at low concentrations. Proc Natl Acad Sci U S A 90: 9552– 9556, 1993.
   PubMed Web of Science ®Google Scholar
• JordanMAWendellKGardinerSDerryWBCoppHWilsonL: Mitotic block induced in HeLa cells by low concentrations of paclitaxel (Taxol) results in abnormal mitotic exit and apoptotic cell death. Cancer Res 56: 816– 825, 1996.
   PubMed Web of Science ®Google Scholar
• BurkOArnoldKAGeickATegudeHEichelbaumM: A role for constitutive androstane receptor in the regulation of human intestinal MDR1 expression. Biol Chem 386: 503– 513, 2005.
   PubMed Web of Science ®Google Scholar
• ChawlaARepaJJEvansRMMangelsdorfDJ: Nuclear receptors and lipid physiology: opening the X-files. Science 294: 1866– 1870, 2001.
   PubMed Web of Science ®Google Scholar
• ChildsSYehRLHuiDLingV: Taxol resistance mediated by transfection of the liver-specific sister gene of P-glycoprotein. Cancer Res 58: 4160– 4167, 1998.
   PubMed Web of Science ®Google Scholar
• FergusonPJBrissonARKoropatnickJVincentMD: Enhancement of cytotoxicity of natural product drugs against multidrug resistant variant cell lines of human head and neck squamous cell carcinoma and breast carcinoma by tesmilifene. Cancer Lett 274: 279– 289, 2009.
   PubMed Web of Science ®Google Scholar
• MarupudiNIHanJELiKWRenardVMTylerBMBremH: Paclitaxel: a review of adverse toxicities and novel delivery strategies. Expert Opin Drug Saf 6: 609– 621, 2007.
   PubMed Web of Science ®Google Scholar
• SpratlinJSawyerMB: Pharmacogenetics of paclitaxel metabolism. Crit Rev Oncol Hematol 61: 222– 229, 2007.
   PubMed Web of Science ®Google Scholar
• FojoTMenefeeM: Mechanisms of multidrug resistance: the potential role of microtubule-stabilizing agents. Ann Oncol 18 (suppl 5): v3– v8, 2007.
   Google Scholar
• RowinskyEKDonehowerRC: Paclitaxel (Taxol). N Engl J Med 332: 1004– 1014, 1995.
   PubMed Web of Science ®Google Scholar
• WeaverBAClevelandDW: Decoding the links between mitosis, cancer, and chemotherapy: the mitotic checkpoint, adaptation, and cell death. Cancer Cell 8: 7– 12, 2005.
   PubMed Web of Science ®Google Scholar
• BlackHSRhodesLE: The potential of omega-3 fatty acids in the prevention of non-melanoma skin cancer. Cancer Detect Prev 30: 224– 232, 2006.
   PubMedGoogle Scholar
• DupertuisYMMeguidMMPichardC: Colon cancer therapy: new perspectives of nutritional manipulations using polyunsaturated fatty acids. Curr Opin Clin Nutr Metab Care 10: 427– 432, 2007.
   PubMed Web of Science ®Google Scholar
• CalderPC: Polyunsaturated fatty acids, inflammatory processes and inflammatory bowel diseases. Mol Nutr Food Res 52: 885– 897, 2008.
   PubMed Web of Science ®Google Scholar
• BenattiPPelusoGNicolaiRCalvaniM: Polyunsaturated fatty acids: biochemical, nutritional and epigenetic properties. J Am Coll Nutr 23: 281– 302, 2004.
   PubMed Web of Science ®Google Scholar
• RussoGL: Dietary n-6 and n-3 polyunsaturated fatty acids: from biochemistry to clinical implications in cardiovascular prevention. Biochem Pharmacol 77: 937– 946, 2009.
   PubMed Web of Science ®Google Scholar
• XuCLiCYKongAN: Induction of phase I, II and III drug metabolism/transport by xenobiotics. Arch Pharm Res 28: 249– 268, 2005.
   PubMed Web of Science ®Google Scholar
• BurkOArnoldKANusslerAKSchaeffelerEEfimovaEAveryBAAveryMAFrommMFEichelbaumM: Antimalarial artemisinin drugs induce cytochrome P450 and MDR1 expression by activation of xenosensors pregnane X receptor and constitutive androstane receptor. Mol Pharmacol 67: 1954– 1965, 2005.
   PubMed Web of Science ®Google Scholar
• GeickAEichelbaumMBurkO: Nuclear receptor response elements mediate induction of intestinal MDR1 by rifampin. J Biol Chem 276: 14581– 14587, 2001.
   PubMed Web of Science ®Google Scholar
• HaslamISJonesKColemanTSimmonsNL: Rifampin and digoxin induction of MDR1 expression and function in human intestinal (T84) epithelial cells. Br J Pharmacol 154: 246– 255, 2008.
   PubMed Web of Science ®Google Scholar
• TakaraKTakagiKTsujimotoMOhnishiNYokoyamaT: Digoxin up-regulates multidrug resistance transporter (MDR1) mRNA and simultaneously down-regulates steroid xenobiotic receptor mRNA. Biochem Biophys Res Commun 306: 116– 120, 2003.
   PubMed Web of Science ®Google Scholar
• StanleyLAHorsburghBCRossJScheerNWolfCR PXR and CAR: Nuclear receptors which play a pivotal role in drug disposition and chemical toxicity. Drug Metab Rev 38: 515– 597, 2006.
   PubMed Web of Science ®Google Scholar